EU and India set Jan. 18 date for talks on GVK drug ban

India and the European Union plan to meet on Jan. 18 in Brussels to restart talks on the EU ban of 700 drugs that were tested by Hyderabad-based GVK Biosciences. India said officials from the commerce ministry and the country's Pharmaceuticals Export Promotion Council will travel to Brussels, where "several issues are likely to come up during the meeting, including GVK Biosciences," one official said. The EU ban on the drugs led India to call off trade talks on the Broadbased Trade and Investment Agreement, and India said it was "disappointed" in the ban and also took issue with claims by European investigators at the way the tests were performed. The ban was said to have threatened $1 billion in Indian exports to the EU by March 2016. Report

Suggested Articles

New legal complaints focus on eight Sanofi executives, most of them with local management titles, and 15 managers at distributor Zuellig Pharma.

A self-proclaimed former employee at Novartis’ Beijing office accused the Swiss drugmaker of expensing fake academic events to offer kickbacks to doctors.

A decree includes tax incentives for certain generic drugmakers and uniform insurance standards that apply to both branded drugs and generics.